000307610 001__ 307610
000307610 005__ 20260113155325.0
000307610 0247_ $$2doi$$a10.3390/cells15010086
000307610 0247_ $$2pmid$$apmid:41511369
000307610 0247_ $$2pmc$$apmc:PMC12785619
000307610 037__ $$aDKFZ-2026-00082
000307610 041__ $$aEnglish
000307610 082__ $$a570
000307610 1001_ $$aMladenov, Emil$$b0
000307610 245__ $$aEvidence for Quasi-High-LET Biological Effects in Clinical Proton Beams That Suppress c-NHEJ and Enhance HR and Alt-EJ.
000307610 260__ $$aBasel$$bMDPI$$c2026
000307610 3367_ $$2DRIVER$$aarticle
000307610 3367_ $$2DataCite$$aOutput Types/Journal article
000307610 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1768315933_488982
000307610 3367_ $$2BibTeX$$aARTICLE
000307610 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000307610 3367_ $$00$$2EndNote$$aJournal Article
000307610 500__ $$a#DKTKZFB26#
000307610 520__ $$aProtons are conventionally regarded as a low-linear energy transfer (low-LET) radiation modality with a relative biological effectiveness (RBE) of 1.1, suggesting direct mechanistic similarity to X-rays in the underpinning biological effects. However, exposure to spread-out Bragg peak (SOBP) protons reveals instructive deviations from this assumption. Indeed, proton beams have a maximum LET of ~5 keV/µm but display reduced reliance on classical non-homologous end joining (c-NHEJ) as well as an increased dependence on homologous recombination (HR) and alternative end joining (alt-EJ). These features are well described in cells exposed to high-LET radiation and typically manifest between 100 and 150 keV/µm. We hypothesized that this apparent discrepancy reflects biological consequences of proton-beam properties that remain uncharacterized. In the present study, we outline exploratory experiments aiming at uncovering such mechanisms. We begin by investigating for both entrance and SOBP protons the dose-dependent engagement of HR we recently showed for X-rays. Consistent with our previous findings with X-rays, HR engagement after exposure to both types of proton beams declined with dose, from ~80% at 0.2 Gy to less than 20% at higher doses. RAD51/γH2AX foci ratios, reflecting HR engagement, were modestly higher following proton irradiation, in line with increased HR utilization. G2-checkpoint activation, previously linked to HR, was also stronger after exposure to protons, as was DNA end resection. Moreover, the formation of structural chromosomal abnormalities (SCAs) was higher for SOBP than entrance protons and X-rays. Collectively, our results suggest quasi-high-LET characteristics for proton beams and raise the question as to the physical proton properties that underpin them. We discuss that the commonly employed definition of LET may be insufficient for this purpose.
000307610 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000307610 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000307610 650_7 $$2Other$$aDNA double strand breaks (DSBs)
000307610 650_7 $$2Other$$aalternative end joining (alt-EJ)
000307610 650_7 $$2Other$$aclassical non-homologous end joining (c-NHEJ)
000307610 650_7 $$2Other$$ahomologous recombination (HR)
000307610 650_7 $$2Other$$aionizing radiation (IR)
000307610 650_7 $$2Other$$alinear energy transfer (LET)
000307610 650_7 $$2Other$$aproton radiation
000307610 650_7 $$2Other$$arelative biological effectiveness (RBE)
000307610 650_7 $$2Other$$astructural chromosomal abnormalities (SCAs)
000307610 650_7 $$2NLM Chemicals$$aProtons
000307610 650_2 $$2MeSH$$aLinear Energy Transfer
000307610 650_2 $$2MeSH$$aHumans
000307610 650_2 $$2MeSH$$aDNA End-Joining Repair: radiation effects
000307610 650_2 $$2MeSH$$aProtons
000307610 650_2 $$2MeSH$$aHomologous Recombination: radiation effects
000307610 650_2 $$2MeSH$$aProton Therapy
000307610 650_2 $$2MeSH$$aDose-Response Relationship, Radiation
000307610 650_2 $$2MeSH$$aX-Rays
000307610 7001_ $$aPressler, Mina$$b1
000307610 7001_ $$aMladenova, Veronika$$b2
000307610 7001_ $$00000-0001-9696-1006$$aSoni, Aashish$$b3
000307610 7001_ $$00000-0001-7610-8489$$aLi, Fanghua$$b4
000307610 7001_ $$aHeinzelmann, Feline$$b5
000307610 7001_ $$aEsser, Johannes Niklas$$b6
000307610 7001_ $$00009-0002-1488-8103$$aHessenow, Razan$$b7
000307610 7001_ $$aGkika, Eleni$$b8
000307610 7001_ $$00000-0003-1058-2107$$aJendrossek, Verena$$b9
000307610 7001_ $$00000-0003-2274-2008$$aTimmermann, Beate$$b10
000307610 7001_ $$00000-0001-6836-0940$$aStuschke, Martin$$b11
000307610 7001_ $$00000-0002-1152-5342$$aIliakis, George$$b12
000307610 773__ $$0PERI:(DE-600)2661518-6$$a10.3390/cells15010086$$gVol. 15, no. 1, p. 86 -$$n1$$p86$$tCells$$v15$$x2073-4409$$y2026
000307610 909CO $$ooai:inrepo02.dkfz.de:307610$$pVDB
000307610 9101_ $$0I:(DE-588b)2036810-0$$60000-0003-1058-2107$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000307610 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-6836-0940$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000307610 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000307610 9141_ $$y2026
000307610 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCELLS-BASEL : 2022$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-08-01T15:15:06Z
000307610 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-08-01T15:15:06Z
000307610 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-08-01T15:15:06Z
000307610 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-08-01T15:15:06Z
000307610 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCELLS-BASEL : 2022$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2025-01-06
000307610 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2025-01-06
000307610 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK Koordinierungsstelle Essen/Düsseldorf$$x0
000307610 980__ $$ajournal
000307610 980__ $$aVDB
000307610 980__ $$aI:(DE-He78)ED01-20160331
000307610 980__ $$aUNRESTRICTED